An in-depth report by the BBC about an ongoing trial of the Monarch eTNS device as a treatment for PTSD among veterans. Dr. Andrew Leuchter, Professor of Psychiatry at UCLA and Principal Investigator of the clinical trial is interviewed about his ongoing work with Trigeminal Nerve Stimulation.
WNDU in Indiana reports on the ongoing trial of the Monarch eTNS system, a collaboration between UCLA and the VA hospital, for veterans suffering from PTSD. The story profiles a veteran on the effects of trigeminal nerve stimulation treatment and discusses its prospects for more widespread clinical use.
KABC7 Eyewitness News in Los Angeles interviews Dr. Andrew Leuchter, lead investigator on a U.S. Army funded trial of eTNS for Veterans with Post-Traumatic Stress Disorder (PTSD), and profiles a veteran enrolled in the trial who benefited from the treatment.
Dr. Christopher DeGiorgio gives an update on clinical studies of eTNS at the June 2014 Epilepsy Pipeline Conference sponsored by the Epilepsy Foundation and the Epilepsy Therapy Project.
ABC7 in San Francisco reports on a study conducted at UCLA and presented at the American Psychiatric Association’s convention. The study found that nightly use of the eTNS resulted in significant improvement in ADHD symptom severity among children ages 7 - 14.
This video provides an overview of the science and clinical data behind eTNS. The footage was taken from a presentation given by Drs. Christopher DeGiorgio, and Colin Kealey at the 2013 Royal Society of Medicine Innovations Summit, held February 13th in London.
An interview conducted by the UK Epilepsy Society with Dr. Christopher DeGiorgio, inventor of eTNS, and Patrick Miller of NeuroSigma. This video shows how the eTNS device works and is a good reference for patients, family members and physicians interested in how eTNS could incorporate into their daily lives.
The Monarch makes local news in this video featuring an interview with a patient who has used the eTNS device to successfully treat their epilepsy.
In the News
March 12, 2019 » First double-blind controlled trial of TNS shows reduced symptoms in some children with ADHD with minimal riskTrigeminal Nerve Stimulation (TNS), a non-medication therapy administered during sleep, shown to be effective and safe in treating children with ADHD.
December 6, 2017 » Bioelectronic medicine is a fast growing alternative to drugsIN 2006 A CLINICAL TRIAL came to the attention of Dr. Andrew Cole, a neurologist and the director of the Epilepsy Service at Massachusetts General Hospital. The trial was to establish the effectiveness of a new device for treating epilepsy, the NeuroPace RNS System. The device intrigued him, because of its potential for addressing the most challenging cases of epilepsy. It also happened to be a new approach to fighting disease — one that may be as revolutionary as drugs were in the 20th century.
February 3rd, 2016 » Trigeminal Nerve Stimulation Offers Hope for PTSD Sufferers A news story from Discover magazine covering external trigeminal nerve stimulation (eTNS) and its use in patients suffering from PTSD. Nightly eTNS treatment was shown to have a significant effect on chronic PTSD symptoms in just 2 months. An ongoing double-blind trial of veterans suffering from PTSD is being being conducted at the West Los Angeles VA.
January 28th, 2016 » Nightly Trigeminal Nerve Stimulation Could Treat PTSD A news article from Popular Science magazine covering the results of a study published in Neuromodulation: Technology at the Neural Interface. The study reported that 12 participants with PTSD underwent nightly external trigeminal nerve stimulation (eTNS) treatments alongside therapy, medication, or both. After 8 weeks, participants saw an average of 30% reduction in the severity of their symptoms.
April 16th, 2014 » UK Epilepsy Patient Has Success with TNSA news story about a UK patient with epilepsy that has used NeuroSigma’s eTNS system for over 14 months. The patient reported both decreased seizures and increased quality of life. His caregivers have been overwhelmed by the difference that eTNS has made in his life.
February 21th, 2013 » External Trigeminal Nerve StimulationDr. Christopher DeGiorgio and and Dr. Colin Kealey present data from their clinical studies explaining how External Trigeminal Nerve Stimulation (eTNS) can be used for the treatment of epilepsy and depression at the Medical Innovations Summit 2013 at the Royal Society of Medicine in London.
September 30th, 2012 » Neurotech Business Report - Vendor ProfileNeuroSigma Pursues Multi-Pronged Strategy in Neurological Disorders Market (pdf)
November 10th, 2011 » 2011 Hallway ConversationsIn this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Christopher de Giorgio, Associate Professor of Neurology at UCLA and Dr. Gregory Worrell, Associate Professor of Neurology, at Mayo Clinic in Rochester, about Devices for Epilepsy: Past, Present and Future.
July 27th, 2011 » New Device Reduces Seizures, No Surgery RequiredNational Public Radio (NPR) Report
July 3rd, 2011 » Stimulating New Therapy For EpilepsyTechnology Review (MIT Press) Magazine Article
February 18th, 2011 » NeuroSigma, Inc. Presents at 6th Annual Neurotechnology Investing and Partnering ConferenceTechnology Conference Panel Event
April 17th, 2009 » New Device Offers Hope for Severe EpilepticsKCAL 9 Television News Story